Search - tctmd.com

Displaying 121 - 140 of 280

Sort: Relevancy | Date

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

Acute MI Rates on the Rise Among Pregnant Women in the US

News Daily News

Acute MI Rates on the Rise Among Pregnant Women in the US

July 24, 2018

PARAMEDIC2: Epinephrine in Cardiac Arrest Is Good for Survival, Bad for the Brain

News Daily News

PARAMEDIC2: Epinephrine in Cardiac Arrest Is Good for Survival, Bad for the Brain

July 19, 2018

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

Medicare’s Bundled Payments Plan Hasn’t Cut Costs (Yet)

News Daily News

Medicare’s Bundled Payments Plan Hasn’t Cut Costs (Yet)

July 18, 2018

Marijuana May Muddle a Chest Pain Diagnosis, CTA Study Hints

News Conference News SCCT 2018

Marijuana May Muddle a Chest Pain Diagnosis, CTA Study Hints

Yael L. Maxwell

July 18, 2018

Discharge Against Medical Advice After PCI Rare but Deadly

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

SCAI Updates Statement on Intracoronary Diagnostic Tools

News Daily News

SCAI Updates Statement on Intracoronary Diagnostic Tools

July 17, 2018

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

July 16, 2018

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

News Daily News

Rivaroxaban Offers Net Reduction in Fatal or Irreversible Events in ACS: ATLAS ACS-2 TIMI-51

Michael O'Riordan

July 06, 2018

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

News Daily News

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

July 03, 2018

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

News Daily News

SGLT2 Inhibitors Work in Type 2 Diabetes Across Levels of CV Risk, Renal Function

July 02, 2018

CVD Prevention and Control Remains a Challenge in India

News Daily News

CVD Prevention and Control Remains a Challenge in India

June 26, 2018

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

News Daily News

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

June 25, 2018

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

News Daily News

Little Impact of Medicare ACOs on Low- and High-Value Revascularization Decisions

June 22, 2018

After Acute MI, 1 in 10 Patients Work Less or Stop Working Altogether

News Daily News

After Acute MI, 1 in 10 Patients Work Less or Stop Working Altogether

June 14, 2018

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

June 08, 2018

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

News Daily News

FDA: Class I Recall for Cardiosave Hybrid IABP Due to ‘Fluid Ingress’

June 07, 2018

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

News Daily News

Shortfalls in MI Care Hit Lowest Socioeconomic Groups the Hardest

June 06, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.